chAIron noted that Takeda and Weave Bio are coming together to support innovation in regulatory workflows across 14 active programmes.
Published
Signal category
Partnerships
Quote
“Takeda (regulatory expertise) and Weave Bio (AI capabilities) are coming together to support innovation in regulatory workflows across 14 active programmes.”
— Razi Afghan Ph.D|chAIron team
Company
chAIron
Accelerating Life Sciences’ Program Success with Data-Driven Human Target Validation
- Industry
- Biotechnology Research
- Location
- Lausanne, CH
- Company size
- 12 employees
We harness real-world data, scientific literature, and omics with AI and human expertise to push the frontiers of life sciences. By innovating in human target validation, we accelerate potential, de-risk drug development, and increase asset value. Our expertise closes the translational gap between advanced analytics, complex biology, and market dynamics, providing our pharmaceutical and biotechnological partners with a holistic strategic roadmap of their assets and bringing treatments to patients sooner.
Founded 2023